R&D When costing and compliance collide Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
News FDA ramps up unannounced inspections of foreign facilities Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.
Digital How to fix pharma's content duplication problem At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.
R&D Quality compliance in the digital era Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products.
Sales & Marketing Sponsored 12 Questions with Jackie Marchington Jackie Marchington is Head of Compliance and Ethics for IPG Health Medical Communications.
Sales & Marketing Eliminate swivel chair processes to streamline claims manage... Healthcare professionals (HCPs) rely on biopharma companies for accurate drug information. Out-of-date claims can damage both brand reputation and industry credibility.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
